Company Filing History:
2 out of 1,603 
1 out of 10 
1 out of 15 Years Active: 1994-1999
Title: Rainer Metternich: Innovator in Pharmaceutical Compositions
Introduction
Rainer Metternich is a notable inventor based in Inzlingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for trypsin-like enzymes. With a total of 4 patents, his work has implications for therapeutic methods aimed at inhibiting thrombin.
Latest Patents
Metternich's latest patents focus on pharmaceutical compositions that comprise specific compounds designed to inhibit thrombin. One of his notable inventions includes a composition where X is either hydrogen or an N-protecting group, Y consists of 1-10 alpha-amino acids, and R is a C1-4 alkyl group. These compositions are crucial in therapeutic methods for managing thrombin activity. Another patent similarly addresses inhibitors of trypsin-like enzymes, emphasizing the utility of these compounds in medical applications.
Career Highlights
Throughout his career, Rainer Metternich has worked with prominent companies such as Sandoz GmbH and the Thrombosis Research Institute. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in the field.
Collaborations
Metternich has collaborated with esteemed colleagues, including Goran Karl Claeson and Manfred Hans Philipp. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in pharmaceuticals.
Conclusion
Rainer Metternich's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact therapeutic methods for inhibiting thrombin, showcasing the importance of innovation in medicine.